Ch. ROUZIOUX, Ph.D.; F. BRUN-VEZINET, M.D.; A.M. COUROUCÉ, Ph.D.; C. GAZENGEL, M.D.; D. VERGOZ, M.D.; J. DESMYTER, M.D.; J. VERMYLEN, M.D.; C. VERMYLEN, M.D.; D. KLATZMANN, M.D.; D. GEROLDI, M.D.; C. BARREAU, Ph.D.; F. BARRÉ-SINOUSSI, Ph.D.; J.C. CHERMANN, Ph.D.; D. CHRISTOL, M.D.; L. MONTAGNIER, M.D.
ROUZIOUX C, BRUN-VEZINET F, COUROUCÉ A, GAZENGEL C, VERGOZ D, DESMYTER J, et al. Immunoglobulin G Antibodies to Lymphadenopathy-Associated Virus in Differently Treated French and Belgian Hemophiliacs. Ann Intern Med. 1985;102:476-479. doi: 10.7326/0003-4819-102-4-476
Download citation file:
Published: Ann Intern Med. 1985;102(4):476-479.
Immunoglobulin G antibodies to lymphadenopathy-associated virus have been detected in two groups of French hemophiliacs and in one group of Belgian hemophiliacs, whose mode of treatment differed. Seropositivity was more frequent (58.9%) in patients heavily transfused with blood products of French and foreign origin than in less frequently transfused persons (10.3%). The Belgian group, treated only with local products, showed the lowest frequency of seropositivity (3.4%). In healthy French controls, 1 of 330 had antibody to the virus. The results indicate transmission of lymphadenopathy-associated virus via blood-derived products.
Learn more about subscription options.
Register Now for a free account.
HIV, Infectious Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only